Skip to Main Content
TRC_Prescriber's Letter NEW
Menu
    • Products
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber's Letter
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Charts
    • COVID-19 Resources
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Journal Club
  • Drug Charts
    • First-Time Generics
    • New Drugs
  • Help
    • User Support
    • Contact Us
  • GO TO CE/CME & Training

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

COMING SOON: In the next few weeks, Prescriber's Letter is becoming Prescriber Insights, with all the high-quality content you trust, but delivered in profession-specific editions. As the updates push to your account, you will begin to see references to Prescriber Insights and a prompt to select your profession-specific edition.
  1. Home
  2. Browse
  3. Psychiatry
  4. Depression
  5. Drugs
  6. SNRIs

SNRIs

  • ADHD (81)
  • Agitation (3)
  • Anxiety (26)
  • Bipolar Disorder (18)
  • Depression (270)
    • Cardiovascular Disease and Depression (12)
    • Drugs (240)
      • Atypical Antipsychotics (79)
      • Benzodiazepines (54)
      • Bupropion (54)
      • MAOIs (16)
      • SNRIs (102)
      • SSRIs (130)
      • TCAs (53)
      • Typical Antipsychotics (4)
    • Natural Medicines/Supplements (15)
    • Pediatrics (16)
    • Post-Traumatic Stress Disorder (11)
    • Pregnancy (10)
    • Seasonal Affective Disorder (6)
    • Treatment-Resistant Depression (27)
  • Mental Health (28)
  • Resources (179)
  • Schizophrenia (62)
  • Sleep Disorders (98)
  • Substance Use Disorder (250)
76 - 90 of 102 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Article: New generic versions of venlafaxine will create MORE confusion August 2010
Chart: State Regulations on Generic Substitution August 2010
Chart: Comparison of Venlafaxine and Desvenlafaxine August 2010
Article: Interaction alerts often pop up about possible serotonin syndrome when patients get more than one serotonergic drug October 2009
Article: new opioid analgesic called Nucynta (new-SINN-tah, tapentadol) July 2009
Article: Nuvigil launch brings up more questions about whether new isomers or metabolites of existing drugs are better than the original July 2009
Commentary: Nuvigil (Armodafinil) July 2009
Chart: Follow-on Drugs: Therapeutic Benefit or Economic Burden? July 2009
Article: ads promoting Savella (milnacipran) as the first drug approved ONLY for fibromyalgia March 2009
Commentary: New Drug: Savella (Milnacipran) March 2009
Guideline: Management of fibromyalgia syndrome in adults (2009) March 2009
Article: how Pristiq compares to venlafaxine (Effexor XR, etc) February 2009
Article: treating depression in patients with coronary artery disease or after an MI January 2009
Article: If you prescribe Effexor XR, you'll get calls to substitute with a new once-a-day extended-release venlafaxine tablet January 2009
Commentary: New Venlafaxine Extended-Release Formulation January 2009
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved